HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) Supplemental Data All Versions of this Article: jnumed.107.048504v1 49/4/517    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Related articles in JNM Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mullani, N. A. Articles by Abbruzzese, J. L. Search for Related Content PubMed PubMed Citation Articles by Mullani, N. A. Articles by Abbruzzese, J. L.

Tumor Blood Flow Measured by PET Dynamic Imaging of First-Pass ¹⁸F-FDG Uptake: A Comparison with ¹⁵O-Labeled Water-Measured Blood Flow

¹ University of Texas Medical School–Houston, Houston, Texas; and ² University of Texas M.D. Anderson Cancer Center, Houston, Texas

Correspondence: For correspondence or reprints contact: Nizar A. Mullani, BSc, 719 Santa Maria, Sugar Land, TX 77478. E-mail: mullani{at}tlite.com

PET molecular imaging of ¹⁵O-labeled water is the gold standard for measuring blood flow in humans. However, this requires an on-site cyclotron to produce the short-lived ¹⁵O tracer, which is cost-prohibitive for most clinical PET centers. The purpose of this study was to determine if the early uptake of ¹⁸F-FDG could be used to measure regional blood flow in tumors in the absence of ¹⁵O-water. Methods: PET scans were obtained in patients being evaluated for tumor perfusion and glucose metabolism in a phase I dose-escalating protocol for endostatin, a novel antiangiogenic agent. A 2-min perfusion scan was performed with a bolus injection of 2,220 MBq (60 mCi) of ¹⁵O-water, which was followed by a 370-MBq (10 mCi) dose of ¹⁸F-FDG. Four sequential scans of ¹⁸F-FDG uptake were acquired, consisting of an early 2-min uptake scan—or first-pass scan—and 3 sequential 15-min late ¹⁸F-FDG uptake scans. Regions of interest (ROIs) were drawn on 2 or more tumor sites and on back muscle, as a control ROI, for each patient. Arterial blood concentration was derived from the PET scans by drawing an ROI over a large artery in the field of view. Blood flow was computed with a simple 1-compartment blood flow model using the first 2 min of data after injection. Results: Blood flow estimated from the early uptake of ¹⁸F-FDG was linearly correlated with ¹⁵O-measured blood flow, with an intercept of 0.01, a slope of 0.86, and an R² regression coefficient of 0.74 (r = 0.86). The ¹⁸F-FDG tumor extraction fraction relative to ¹⁵O-water averaged 0.86. A preliminary case study of a patient with prostate cancer confirms the utility of the first-pass ¹⁸F-FDG blood flow analysis in tumor diagnosis. Conclusion: These results suggest that the first-pass uptake of ¹⁸F-FDG may provide an estimate of perfusion in a tumor within the limitations of incomplete extraction of ¹⁸F-FDG compared with ¹⁵O-water.

Key Words: PET • ¹⁸F-FDG • tumor • perfusion • blood flow • ¹⁵O • molecular imaging

COPYRIGHT © 2008 by the Society of Nuclear Medicine, Inc.

Related articles in JNM:

This Month in JNM

JNM 2008 49: 11A-12A. [Full Text]  

This article has been cited by other articles:

				J. H. Lee, E. L. Rosen, and D. A. Mankoff The Role of Radiotracer Imaging in the Diagnosis and Management of Patients with Breast Cancer: Part 2--Response to Therapy, Other Indications, and Future Directions J. Nucl. Med., May 1, 2009; 50(5): 738 - 748. [Abstract] [Full Text] [PDF]

				K. B. Contractor and E. O. Aboagye Monitoring Predominantly Cytostatic Treatment Response with 18F-FDG PET J. Nucl. Med., May 1, 2009; 50(Suppl_1): 97S - 105S. [Abstract] [Full Text] [PDF]